Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma

This study has been completed.
Information provided by:
Kyowa Kirin Pharmaceutical Development, Inc. Identifier:
First received: April 5, 2007
Last updated: January 31, 2011
Last verified: January 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2011
  Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)